Neuropeptide Y-based recombinant peptides ameliorate bone loss in mice by regulating hematopoietic stem/progenitor cell mobilization |
Park, Min Hee
(Stem Cell Neuroplasticity Research Group, Kyungpook National University)
Kim, Namoh (Stem Cell Neuroplasticity Research Group, Kyungpook National University) Jin, Hee Kyung (Stem Cell Neuroplasticity Research Group, Kyungpook National University) Bae, Jae-sung (Stem Cell Neuroplasticity Research Group, Kyungpook National University) |
1 | Park MH, Jin HK, Min WK et al (2015) Neuropeptide Y regulates the hematopoietic stem cell microenvironment and prevents nerve injury in the bone marrow. EMBO J 34, 1648-1660 DOI |
2 | Park MH, Lee JK, Kim N et al (2016) Neuropeptide Y Induces Hematopoietic Stem/Progenitor Cell Mobilization by Regulating Matrix Metalloproteinase-9 Activity Through Y1 Receptor in Osteoblasts. Stem Cells 34, 2145-2156 DOI |
3 | Rose JB, Crews L, Rockenstein E et al (2009) Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease. J Neurosci 29, 1115-1125 DOI |
4 | Ehninger A and Trumpp A (2011) The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 208, 421-428 DOI |
5 | Bae JS, Furuya S, Shinoda Y et al (2005) Neurodegeneration augments the ability of bone marrow-derived mesenchymal stem cells to fuse with Purkinje neurons in Niemann-Pick type C mice. Hum Gene Ther 16, 1006-1011 DOI |
6 | van den Bergh JP, van Geel TA and Geusens PP (2012) Osteoporosis, frailty and fracture: implications for case finding and therapy. Nat Rev Rheumatol 8, 163-172 DOI |
7 | Manolagas SC (2000) Sex Steroids and Bone. Endocr Rev 21, 115-137 |
8 | NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285, 785-795 DOI |
9 | Kim TH, Jung JW, Ha BG et al (2011) The effects of luteolin on osteoclast differentiation, functionin vitro and ovariectomy-induced bone loss. J Nutr Biochem 22, 8-15 DOI |
10 | Kim T, Ha H, Shim KS, Cho WK and Ma JY (2013) The anti-osteoporotic effect of Yijung-tang in an ovariectomized rat model mediated by inhibition of osteoclast differentiation. J Ethnopharmacol 146, 83-89 DOI |
11 | Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7, 292-304 DOI |
12 | Ding L, Saunders TL, Enikolopov G and Morrison SJ (2012) Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457-462 DOI |
13 | Butler JM, Nolan DJ, Vertes EL et al (2010) Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 6, 251-264 DOI |
14 | Levesque JP, Helwani FM and Winkler IG (2010) The endosteal ‘osteoblastic’ niche and its role in hematopoietic stem cell homing and mobilization. Leukemia 24, 1979-1992 DOI |
15 | Mendez-Ferrer S, Michurina TV, Ferraro F et al (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829-834 DOI |
16 | Sugiyama T, Kohara H, Noda M and Nagasawa T (2006) Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25, 977-988 DOI |
17 | Tanaka Y, Morimoto I, Nakano Y et al (1995) Osteoblasts are regulated by the cellular adhesion through ICAM-1 and VCAM-1. J Bone Miner Res 10, 1462-1469 |
18 | Jung Y, Wang J, Schneider A et al (2006) Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone 38, 497-508 DOI |
19 | Katayama Y, Battista M, Kao WM et al (2006) Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124, 407-421 DOI |
20 | Im JY, Min WK, Park MH et al (2014) AMD3100 improves ovariectomy-induced osteoporosis in mice by facilitating mobilization of hematopoietic stem/progenitor cells. BMB Rep 47, 439-444 DOI |
21 | Ishii M, Egen JG, Klauschen F et al (2009) Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458, 524-528 DOI |
22 | Zukowska-Grojec Z (1995) Neuropeptide Y. A novel sympathetic stress hormone and more. Ann NY Acad Sci 771, 219-233 DOI |
23 | Kalra SP and Kalra PS (2004) NPY and cohorts in regulation appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides 38, 201-211 DOI |
24 | Arai F, Hirao A, Ohmura M et al (2004) Tie2/angiopoietin-1 signaling regulates hematopoietic stem cells quiescence in the bone marrow niche. Cell 118, 149-161 DOI |
25 | Kuo LE, Kitlinska JB, Tilan JU et al (2007) Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13, 803-811 DOI |